138 related articles for article (PubMed ID: 4970028)
21. [Beta-blocking drugs in cardiac therapy].
Pretolani E
G Clin Med; 1968 Feb; 49(2):221-8. PubMed ID: 4392710
[No Abstract] [Full Text] [Related]
22. [Adrenergic beta-receptor blocking agents in the treatment of cardiothyreosis (arrhythmias, angina pectoris)].
Popovici D
Stud Cercet Endocrinol; 1969; 20(1):63-74. PubMed ID: 5343647
[No Abstract] [Full Text] [Related]
23. [Therapy with "nitroglycerin" in coronary disease].
Westermann KW
Anasthesiol Intensivmed Prax; 1977 Feb; 13(1):47-8. PubMed ID: 406808
[No Abstract] [Full Text] [Related]
24. Treatment of angina pectoris with beta-receptor blockade, mode of action.
Björntorp P
Acta Med Scand; 1968 Oct; 184(4):259-62. PubMed ID: 4974645
[No Abstract] [Full Text] [Related]
25. [Evaluation of the clinical effects of a beta-adrenergic blocking agent: butydrine].
Bianchi G; Guzalian A; Cerri B
Minerva Cardioangiol; 1968 Oct; 16(10):982-6. PubMed ID: 5727893
[No Abstract] [Full Text] [Related]
26. [Longtern therapy of coronary failure].
Meesmann W
Munch Med Wochenschr; 1968 Apr; 110(17):1066-73. PubMed ID: 4974159
[No Abstract] [Full Text] [Related]
27. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
Volta G; Pavarani A; Barbaresi F; Starcich R
G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
[No Abstract] [Full Text] [Related]
28. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
Musial W; Tracz W; Krzemińska-Pakula M
Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
[No Abstract] [Full Text] [Related]
29. [Paradoxal reaction to beta-adrenergic blocking therapy of coronary angina].
Dal Palù C; Gasparotto G; Stritoni P
Boll Soc Ital Cardiol; 1967; 12(2):104-8. PubMed ID: 5606862
[No Abstract] [Full Text] [Related]
30. Drugs for angina.
Br Med J; 1969 Jun; 2(5658):677-8. PubMed ID: 4977329
[No Abstract] [Full Text] [Related]
31. [Background of angina pectoris pharmacotherapy].
van Zwieten PA
Ned Tijdschr Geneeskd; 1976 Sep; 120(37):1571-4. PubMed ID: 824558
[No Abstract] [Full Text] [Related]
32. [The influencing of angina pectoris with drugs in a work experiment].
Kaltenbach M; Hunscha H; Schellhorn W
Z Gesamte Inn Med; 1967 Sep; 22(18):Suppl:275-7. PubMed ID: 4969824
[No Abstract] [Full Text] [Related]
33. [Beta-blocking agents in the treatment of angina pectoris].
Lund-Larsen PG
Tidsskr Nor Laegeforen; 1972 Feb; 92(5):355-7. PubMed ID: 4401368
[No Abstract] [Full Text] [Related]
34. [Clinical trials with the beta adrenergic blocking agent Visken].
Holló J; Szám I
Orv Hetil; 1972 Jun; 113(26):1530-3. PubMed ID: 5038972
[No Abstract] [Full Text] [Related]
35. [Adrenergic beta receptor blockaders in the treatment of angina pectoris].
Londres G
Hospital (Rio J); 1969 Oct; 76(4):1179-82. PubMed ID: 4391342
[No Abstract] [Full Text] [Related]
36. [Beta blocking therapy in cardiac rhythm disorders and angina pectoris].
Di Matteo J; Vacheron A; Heulin A
Therapeutique; 1972 Feb; 48(2):101-4. PubMed ID: 4403141
[No Abstract] [Full Text] [Related]
37. [An organic nitrate drug for long term therapy and prevention of angina pectoris attacks].
Kaiser W; Klepzig H
Med Welt; 1968 Aug; 33():1786-90. PubMed ID: 4976588
[No Abstract] [Full Text] [Related]
38. [Temporary regression of apparently stable left branch blocks. Electrophysiological consideration on 3 cases].
Di Giacomo V; Carmenini G
Boll Soc Ital Cardiol; 1978; 23(5):932-46. PubMed ID: 261863
[No Abstract] [Full Text] [Related]
39. A single blind trial of Trasicor (Ciba 39,089-Ba) in angina pectoris.
Turner AS; Wilson DF
Isr J Med Sci; 1969; 5(4):738-40. PubMed ID: 4980553
[No Abstract] [Full Text] [Related]
40. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients].
Saner R
Therapie; 1970; 25(2):393-501. PubMed ID: 4403159
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
